Browsing all posts in BiotechBlog.

Biotechnology Career Development

Two upcoming talks on biotechnology career development strategies at Johns Hopkins campuses:
Homewood Campus
Friday, Oct. 17th 2008 5:30-7:30pm
Remsen Hall Rm 101
3400 North Charles Street
East Baltimore Campus
Wednesday, Oct. 22nd 2008 5:30-7:30pm
Wood Basic Science Auditorium
725 Wolfe Street
Signed copies of my books will also be available for sale. For more details, contact connect@hopkinsbiotechnetwork.org.

Seeking experienced industry insiders for book series

I’d like to build on the success of my “Best Practices in Biotechnology…” book series by producing more edited compilations focused on discrete industry topics such as:

Marketing
IP management
R&D management
Communications
etc.

If you are interested in leading one of these projects and editing a topical compilation, please visit the Logos Press Submission Guidelines and tell me about your [...]

Drug Patent Expirations in October 2008

Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in October2008
*Drugs may be covered by multiple patents

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration

CASODEX
Astrazeneca
bicalutamide
4,636,505
Oct 1, 2008

CONDYLOX
Watson Pharms
podofilox
5,057,616
Oct 15, 2008

COSOPT
Merck
dorzolamide hydrochloride; timolol maleate
4,797,413
Oct 28, 2008

ELIGARD
Qlt Usa
leuprolide acetate
4,938,763
Oct 3, 2008

ELIGARD
Qlt Usa
leuprolide acetate
5,733,950
Oct 3, 2008

ELIGARD
Qlt Usa
leuprolide acetate
5,739,176
Oct 3, 2008

ELIGARD
Qlt Usa
leuprolide acetate
RE37950
Oct 3, 2008

FERIDEX I.V.
Amag Pharms Inc
ferumoxides
5,055,288
Oct 8, 2008

GASTROMARK
Amag Pharms Inc
ferumoxsil
5,055,288
Oct 8, 2008

IONSYS
Alza
fentanyl hydrochloride
5,232,438
Oct 3, 2008

MIRCETTE
Duramed
desogestrel; ethinyl [...]

When will the U.S. develop concise generic biologic rules?

A lot of people have been asking my opinion on when a concise generic biologic regulatory pathway will emerge in the United States, and I give them all the same answer: Later.
In my opinion complex regulatory schemes are not areas in which the United States can effectively lead. Why not? Because the size of the [...]

Commercializing biotechnology in China

I recently had the opportunity to conduct a brief interview with Mireille Gingras, Ph.D. President and CEO of HUYA Bioscience on doing business with and in China:
Tell me about HUYA and what makes the company unique?
HUYA Bioscience International has pioneered the most innovative and productive approach for pharmaceutical co-development between the U.S. and China. [...]

Drug Patent Expirations in September 2008

Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in September 2008
*Drugs may be covered by multiple patents

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration

ANDRODERM
Watson Labs
testosterone
4,855,294
Sep 6, 2008

AVITA
Mylan Bertek
tretinoin
5,045,317
Sep 3, 2008

DDAVP
Sanofi Aventis Us
desmopressin acetate
5,047,398
Sep 10, 2008

OPANA ER
Endo Pharms
oxymorphone hydrochloride
5,128,143
Sep 19, 2008

RESCULA
R Tech Ueno Ltd
unoprostone isopropyl
5,001,153
Sep 19, 2008

Courtesy of DrugPatentWatch.com